Fluicell AB (OSTO:FLUI) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 01, 2026)


OSTO:FLUI Fluicell AB OSTO:FLUI
54 GF Score
Price kr30.90
GF Value kr34.58
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Fluicell AB Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Fluicell AB's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

OSTO:FLUI vs VRTX, REGN, ALNY: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Fluicell AB's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fluicell AB Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fluicell AB's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Fluicell AB's Margin of Safety % (DCF Earnings Based) falls into.


OSTO:FLUI
54GF Score
Fluicell AB OSTO:FLUI
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fluicell AB (OSTO:FLUI) Overvalued in 2026?

Based on GuruFocus' analysis, Fluicell AB stock appears to be undervalued. The current stock price of kr30.90 is trading 10.6% below its estimated GF Value™ of kr34.58. GuruFocus considers Fluicell AB to be Modestly Undervalued.

Key valuation signals for OSTO:FLUI:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: kr34.58 vs. price of kr30.90 (10.6% below fair value)
  • GF Score™: 54/100 with 4 warning signs

No single metric tells the full story. See the OSTO:FLUI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fluicell AB Business Description

Other Exchanges 5J90:Germany
Address Flojelbergsgatan 8C, Molndal, Gothenburg, SWE, 431 37
Fluicell AB is a Swedish life science company that conducts development in regenerative medicine and human tissue-based screening models for drug development, with a particular focus on the areas of type 1 diabetes, cardiac safety screening models, and kidney diseases. The company's platform for the production of human tissue that is based on Fluicell's technology for high-resolution 3D bioprinting, and which enables the creation of tissue-based products for use in drug development and regenerative medicine.
54GF Score

Get the complete analysis for OSTO:FLUI

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr30.90
Price
kr34.58
GF Value